Literature DB >> 24649980

Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.

Lieke C J van den Berk1, Bas J H Jansen, Stuart Snowden, Kim G C Siebers-Vermeulen, Christian Gilissen, Gesine Kögler, Carl G Figdor, Craig E Wheelock, Ruurd Torensma.   

Abstract

Immune suppression is a very stable property of multipotent stromal cells also known as mesenchymal stem cells (MSCs). All cell lines tested showed robust immune suppression not affected by a long culture history. Several mechanisms were described to account for this capability. Since several of the described mechanisms were not causing the immune suppression, the expression pattern of cord-blood-derived MSCs by microarray experiments was determined. Dendritic cells cocultured with cord blood MSCs were compared with cord blood MSCs. Putative immune suppressive candidates were tested to explain this inhibition. We find that cord blood MSCs themselves are hardly immunogenic as tested with allogeneic T-cells. Dendritic cells cocultured with second-party T-cells evoked abundant proliferation that was inhibited by third-party cord blood MSCs. Optimal inhibition was seen with one cord blood MSC for every dendritic cell. Blocking human leukocyte antigen G only saw partial recovery of proliferation. Several cytokines, gangliosides, enzymes like arginase, NO synthase, and indole amine 2,3-dioxygenase as well as the induction of Treg were not involved in the inhibition. The inhibiting moiety was identified as prostaglandin B2 by lipid metabolite analysis of the culture supernatant and confirmed with purified prostaglandin B2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24649980      PMCID: PMC4085994          DOI: 10.1089/scd.2013.0433

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  67 in total

1.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

Authors:  Oscar K Lee; Tom K Kuo; Wei-Ming Chen; Kuan-Der Lee; Shie-Liang Hsieh; Tain-Hsiung Chen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

2.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

3.  Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

Authors:  F Vianello; F Dazzi
Journal:  Leukemia       Date:  2008-03       Impact factor: 11.528

4.  Mesenchymal cells recruit and regulate T regulatory cells.

Authors:  Mauro Di Ianni; Beatrice Del Papa; Maria De Ioanni; Lorenzo Moretti; Elisabetta Bonifacio; Debora Cecchini; Paolo Sportoletti; Franca Falzetti; Antonio Tabilio
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

Review 5.  Mesenchymal stromal cells: tissue engineers and immune response modulators.

Authors:  Lieke C J van den Berk; Carl G Figdor; Ruurd Torensma
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008 Sep-Oct       Impact factor: 4.291

6.  A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs.

Authors:  Diana Campioni; Roberta Rizzo; Marina Stignani; Loredana Melchiorri; Luisa Ferrari; Sabrina Moretti; Antonio Russo; Gian Paolo Bagnara; Laura Bonsi; Francesco Alviano; Giacomo Lanzoni; Antonio Cuneo; Olavio R Baricordi; Francesco Lanza
Journal:  Cytometry B Clin Cytom       Date:  2009-05       Impact factor: 3.058

7.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

8.  A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.

Authors:  R Rizzo; D Campioni; M Stignani; L Melchiorri; G P Bagnara; L Bonsi; F Alviano; G Lanzoni; S Moretti; A Cuneo; F Lanza; O R Baricordi
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

9.  Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction.

Authors:  A Ghodsizad; M Niehaus; G Kögler; U Martin; P Wernet; C Bara; N Khaladj; A Loos; M Makoui; J Thiele; M Mengel; M Karck; H M Klein; A Haverich; A Ruhparwar
Journal:  Heart       Date:  2008-06-02       Impact factor: 5.994

10.  Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells.

Authors:  Hiroshi Shiraishi; Hideyuki Yoshida; Kazuko Saeki; Yoshiki Miura; Satoko Watanabe; Takuma Ishizaki; Masayuki Hashimoto; Giichi Takaesu; Takashi Kobayashi; Akihiko Yoshimura
Journal:  Int Immunol       Date:  2008-07-17       Impact factor: 4.823

View more
  7 in total

1.  Host Metabolic Response in Early Lyme Disease.

Authors:  Bryna L Fitzgerald; Claudia R Molins; M Nurul Islam; Barbara Graham; Petronella R Hove; Gary P Wormser; Linden Hu; Laura V Ashton; John T Belisle
Journal:  J Proteome Res       Date:  2020-01-09       Impact factor: 4.466

2.  Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.

Authors:  Eliana Amati; Sabrina Sella; Omar Perbellini; Alberta Alghisi; Martina Bernardi; Katia Chieregato; Chiara Lievore; Denise Peserico; Manuela Rigno; Anna Zilio; Marco Ruggeri; Francesco Rodeghiero; Giuseppe Astori
Journal:  Stem Cell Res Ther       Date:  2017-01-24       Impact factor: 6.832

3.  Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.

Authors:  Yue Zhang; Xia-Hui Ge; Xue-Jun Guo; Si-Bin Guan; Xiao-Ming Li; Wen Gu; Wei-Guo Xu
Journal:  Biomed Res Int       Date:  2017-06-21       Impact factor: 3.411

4.  Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function.

Authors:  Per Anderson; Elena Gonzalez-Rey; Francisco O'Valle; Francisco Martin; F Javier Oliver; Mario Delgado
Journal:  Stem Cells Int       Date:  2017-01-30       Impact factor: 5.443

5.  Upregulation of CC Chemokine Receptor 7 (CCR7) Enables Migration of Xenogeneic Human Adipose-Derived Mesenchymal Stem Cells to Rat Secondary Lymphoid Organs.

Authors:  Tian Ma; Shao-Liang Luan; Hong Huang; Xing-Kun Sun; Yan-Mei Yang; Hui Zhang; Wei-Dong Han; Hong Li; Yan Han
Journal:  Med Sci Monit       Date:  2016-12-30

6.  RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells.

Authors:  Brian Estevez; Sara Borst; Danuta Jarocha; Varun Sudunagunta; Michael Gonzalez; James Garifallou; Hakon Hakonarson; Peng Gao; Kai Tan; Paul Liu; Sumedha Bagga; Nicholas Holdreith; Wei Tong; Nancy Speck; Deborah L French; Paul Gadue; Mortimer Poncz
Journal:  Blood       Date:  2021-05-13       Impact factor: 22.113

7.  Jagged-2 enhances immunomodulatory activity in adipose derived mesenchymal stem cells.

Authors:  Zhu Xishan; Zhang Bin; Zhao Haiyue; Dou Xiaowei; Bai Jingwen; Zhang Guojun
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.